Specializing in the research, development, and market introduction of first-in-class nutraceuticals, the company focuses on supporting the crucial biological process of apoptosis. Apocaps® CX, one of their flagship products, has been widely embraced by dog lovers, veterinarians, and veterinary oncologists since its launch in 2010, with millions of doses administered.
In addition to Apocaps® CX, Functional Nutriments offers other pioneering veterinary/pet products including EverPup® and Nutrocept®. All products are manufactured in the USA, using 100% natural, human-grade ingredients in an FDA registered and inspected facility.
While details about the last investment and investors are not available, Functional Nutriments' dedication to advancing pet healthcare through innovative nutraceuticals positions it as an intriguing opportunity for potential investors seeking to tap into the expanding pet care industry.